Newswire
Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast…
Akeso, Inc. (HKEX: 9926.HK) today announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or…
The final rule preserves access to care by mitigating proposed cuts to orthopaedic procedures WASHINGTON, Nov. 4, 2026 — The American Association of…
The American Podiatric Medical Association (APMA) is deeply concerned by the decision from the Centers for Medicare and Medicaid Services (CMS) to…
Marini SkinSolutions® (formerly Jan Marini Skin Research®) is proud to announce that Night Zyme® Overnight Glass Skin Resurfacing Complex has been…
Powered by eūvita Health, the educational platform provides scientifically reviewed information on peptide therapies, metabolic health, hormone…
Agreement brings preferred RCM pricing, network-wide KPI initiatives and shared operational best practices to Clarion member practices within ONCare…
Inspired by the energy of a classic New York holiday party, the campaign follows a cast of creators gathering in a festive city apartment and…
Following National Press Club Briefing, Psychiatrist Dr. Carole Lieberman Submitted Official Diagnostic Proposal on "Trump Derangement Syndrome" to…
Support the urgent need for brain research funding Highlights: To advance brain research, the American Academy of Neurology has launched its year-end…
eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter…
Received Regenerative Medicine Advanced Therapy (RMAT) Designation from U.S. FDA for TN-401 Gene Therapy for PKP2-Associated Arrhythmogenic Right…
Data featured in oral presentation at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG)…
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 24,…
– Published the differentiated mechanism of action of EDG-7500 that targets the regulatory light chain – – Phase 3 trial for EDG-7500 in obstructive…
Company Drives Significant Increases in Test Volume and Ordering Providers with Florida Becoming Second Medicaid State Covering Test PreTRM® test…
Hamilton Beach Brands Holding Company (NYSE: HBB) (The Company) today announced results for the third quarter of 2026. Third Quarter 2026 Overview…
PAPZIMEOS® net revenue rose 37% quarter-over-quarter to $72.9 million in the third quarter of 2026 bringing launch-to-date net product revenue to…
